N Wolmark

Summary

Publications

  1. ncbi request reprint Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast
    N Wolmark
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 17:3553-9. 1999
  2. ncbi request reprint Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project Scientific Director s Office, Pittsburgh, PA 15261, USA
    J Clin Oncol 14:1982-92. 1996
  3. ncbi request reprint erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
    S Paik
    National Surgical Adjuvant Breast and Bowel Project, Department of Human Oncology, Allegheny University of Health Sciences, Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 90:1361-70. 1998
  4. ncbi request reprint Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA, USA
    J Clin Oncol 16:2672-85. 1998
  5. ncbi request reprint Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)
    E Mamounas
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA 15212, USA
    J Clin Oncol 17:1349-55. 1999
  6. ncbi request reprint Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
    B Fisher
    B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA, USA
    J Natl Cancer Inst 93:112-20. 2001
  7. ncbi request reprint Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
    N Wolmark
    N Wolmark, D L Wickerham, E R Fisher, B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP Operations Center, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst 92:388-96. 2000
  8. ncbi request reprint Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212 5234, USA
    Lancet 353:1993-2000. 1999
  9. ncbi request reprint The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40
    H D Bear
    Virginia Commonwealth University Massey Cancer Center, Richmond, VA NSABBP Biostatistical Center and University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA University of Pittsburgh Medical Center, Magee Womens Cancer Program, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA NSABP CHUM Hotel Dieu, Montreal, QC, Canada SCCC CCOP, Winston Salem, NC San Juan MBCCOP, San Juan, PR University of California, Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA Kaiser Permanente Northern California, Vallejo, CA NSABP Colorado Cancer Research Program, Denver, CO NSABP Northwest Medical Specialties, Tacoma, WA NSABP Kansas City CCOP, Kansas City, MO Jewish General Hospital, McGill University, Montreal, QC, Canada Genesys Regional Medical Center, Flint, MI Dayton CCOP, Dayton, OH Washington Cancer Institute, Washington Hospital Center, Washington, DC National Surgical Adjuvant Breast and Bowel Project and Aultman Health Foundation, Canton
    J Clin Oncol 29:LBA1005. 2011
  10. ncbi request reprint Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients
    D N Krag
    National Surgical Adjuvant Breast and Bowel Project and University of Vermont, Burlington, VT National Surgical Adjuvant Breast and Bowel Project Biostatistical Center and the University of Pittsburgh, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Aultman Cancer Center, Canton, OH
    J Clin Oncol 28:LBA505. 2010

Collaborators

Detail Information

Publications36

  1. ncbi request reprint Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: results from National Surgical Adjuvant Breast
    N Wolmark
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212, USA
    J Clin Oncol 17:3553-9. 1999
    ..To compare the efficacy of leucovorin-modulated fluorouracil (FU+LV) with that of fluorouracil and levamisole (FU+LEV) or with the combination of FU+LV and levamisole (FU+LV+LEV)...
  2. ncbi request reprint Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of finding
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project Scientific Director s Office, Pittsburgh, PA 15261, USA
    J Clin Oncol 14:1982-92. 1996
    ....
  3. ncbi request reprint erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer
    S Paik
    National Surgical Adjuvant Breast and Bowel Project, Department of Human Oncology, Allegheny University of Health Sciences, Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 90:1361-70. 1998
    ..Overexpression of the erbB-2 protein by breast cancer cells has been suggested to be a predictor of response to doxorubicin. A retrospective study was designed to test this hypothesis...
  4. ncbi request reprint Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA, USA
    J Clin Oncol 16:2672-85. 1998
    ....
  5. ncbi request reprint Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)
    E Mamounas
    National Surgical Adjuvant Breast and Bowel Project Operations and Biostatistical Centers, Pittsburgh, PA 15212, USA
    J Clin Oncol 17:1349-55. 1999
    ....
  6. ncbi request reprint Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
    B Fisher
    B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA, USA
    J Natl Cancer Inst 93:112-20. 2001
    ....
  7. ncbi request reprint Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
    N Wolmark
    N Wolmark, D L Wickerham, E R Fisher, B Fisher, National Surgical Adjuvant Breast and Bowel Project NSABP Operations Center, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst 92:388-96. 2000
    ..This study was carried out to address this issue. An additional aim was to determine whether leucovorin (LV)-modulated 5-fluorouracil (5-FU) is superior to the combination of 5-FU, semustine, and vincristine (MOF) in men...
  8. ncbi request reprint Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212 5234, USA
    Lancet 353:1993-2000. 1999
    ..We did a double-blind randomised controlled trial to find out whether lumpectomy, radiation therapy, and tamoxifen was of more benefit than lumpectomy and radiation therapy alone for DCIS...
  9. ncbi request reprint The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40
    H D Bear
    Virginia Commonwealth University Massey Cancer Center, Richmond, VA NSABBP Biostatistical Center and University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA University of Pittsburgh Medical Center, Magee Womens Cancer Program, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA NSABP CHUM Hotel Dieu, Montreal, QC, Canada SCCC CCOP, Winston Salem, NC San Juan MBCCOP, San Juan, PR University of California, Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA Kaiser Permanente Northern California, Vallejo, CA NSABP Colorado Cancer Research Program, Denver, CO NSABP Northwest Medical Specialties, Tacoma, WA NSABP Kansas City CCOP, Kansas City, MO Jewish General Hospital, McGill University, Montreal, QC, Canada Genesys Regional Medical Center, Flint, MI Dayton CCOP, Dayton, OH Washington Cancer Institute, Washington Hospital Center, Washington, DC National Surgical Adjuvant Breast and Bowel Project and Aultman Health Foundation, Canton
    J Clin Oncol 29:LBA1005. 2011
    ..Secondary aims included assessment of clinical complete response (cCR) rates...
  10. ncbi request reprint Primary outcome results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection (SNR) to conventional axillary dissection (AD) in clinically node-negative breast cancer patients
    D N Krag
    National Surgical Adjuvant Breast and Bowel Project and University of Vermont, Burlington, VT National Surgical Adjuvant Breast and Bowel Project Biostatistical Center and the University of Pittsburgh, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Aultman Cancer Center, Canton, OH
    J Clin Oncol 28:LBA505. 2010
    ..It was designed to detect a survival difference of 2% between the 2 groups at 5 years...
  11. ncbi request reprint HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15
    S Paik
    Division of Pathology, National Surgical Adjuvant Breast and Bowel Project, Allegheny General Hospital, Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 92:1991-8. 2000
    ..We hypothesized that AC would be superior to CMF only in the HER2-positive patients...
  12. ncbi request reprint Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-25
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    J Clin Oncol 17:3374-88. 1999
    ..B-25 was initiated to determine whether further intensifying and increasing the cyclophosphamide dose would yield more favorable results...
  13. ncbi request reprint A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
    N Wolmark
    NSABP, Pittsburgh, PA University of Florida, Gainesville, FL Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA Allegheny General Hospital, Pittsburgh, PA Southeast Cancer Control Consortium CCOP, Goldsboro, NC Atlanta Cancer Care, Atlanta, GA Kaiser Permanente Northern California, Vallejo, CA All Ireland Cooperative Oncology Research Group, Dublin, Ireland
    J Clin Oncol 27:LBA4. 2009
    ..LBA4 Background: The primary aim of this two-arm randomized prospective study was to determine whether mFOLFOX6 plus bevacizumab (mFF6+B) would prolong disease-free survival (DFS) compared to mFOLFOX6 (mFF6) alone...
  14. pmc Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials
    Greg Yothers
    National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, One Sterling Plaza, 201 N Craig St, Pittsburgh, PA 15213, USA
    J Natl Cancer Inst 103:1498-506. 2011
    ..We investigated whether disparities in survival and related endpoints would persist when patients were treated with identical therapies in controlled clinical trials...
  15. ncbi request reprint Effect of serial sectioning and immunohistochemistry (IHC) on sentinel lymph nodes (SLNs) on the false-negative rate (FNR) of SLN biopsy (SLNB): Results from NSABP B-32
    E P Mamounas
    National Surgical Adjuvant Breast and Bowel Project Aultman Health Foundation, Canton, OH National Surgical Adjuvant Breast and Bowel Project Biostatistical Center University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project Allegheny General Hospital, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project University of Vermont, Burlington, VT National Surgical Adjuvant Breast and Bowel Project Department of Pathology, University of Vermont College of Medicine, Burlington, VT Department of Medical Biostatistics, University of Vermont College of Medicine, Burlington, VT
    J Clin Oncol 29:86. 2011
    ..SLN paraffin tissue blocks from negative SLNs were later evaluated centrally for occult metastases deeper in the blocks. In this report we examine the effect of this detailed assessment on the FNR of SLNB...
  16. ncbi request reprint National Surgical Adjuvant Breast and Bowel Project trials in colon cancer
    N Wolmark
    National Surgical Adjuvant Breast and Bowel Project Operations Center, Pittsburgh, PA 15212, USA
    Semin Oncol 28:9-13. 2001
    ....
  17. ncbi request reprint Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Allegheny University of the Health Sciences, Pittsburgh, PA 15212 5234, USA
    J Natl Cancer Inst 90:1371-88. 1998
    ..To test this hypothesis, the National Surgical Adjuvant Breast and Bowel Project initiated the Breast Cancer Prevention Trial (P-1) in 1992...
  18. ncbi request reprint Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project NSABP, 4 Allegheny Center, Suite 602, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst Monogr . 2001
    ..Because it also has been proven effective in women with tumors less than or equal to 1 cm, such therapy might also be considered in the treatment of that patient population...
  19. ncbi request reprint Bevacizumab beginning concurrently with a sequential regimen of doxorubicin and cyclophosphamide followed by docetaxel and capecitabine as neoadjuvant therapy followed by postoperative bevacizumab alone for women with HER2-negative locally advanced breast
    P Rastogi
    National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA University of Pittsburgh, Pittsburgh, PA International Drug Development Institute IDDI, Louvain la Neuve, Belgium Washington Hospital Center, Washington, DC University of Pittsburgh Cancer Institute, Pittsburgh, PA Centre Hospitalier de l Universite Montreal, Montreal, QC, Canada West Michigan Cancer Center, Kalamazoo, MI Cancer Care Specialists of Central Illinois, Effingham, IL Allegheny General Hospital, Pittsburgh, PA
    J Clin Oncol 27:584. 2009
    ..584 Background: Bevacizumab with chemotherapy improves outcomes in patients with metastatic breast cancer. The purpose of this trial was to determine the activity and safety profile of bevacizumab with chemotherapy in women with LABC...
  20. ncbi request reprint Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23
    B Fisher
    National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA 15212 5234, USA
    J Clin Oncol 19:931-42. 2001
    ....
  21. ncbi request reprint The effect on pCR of bevacizumab and/or antimetabolites added to standard neoadjuvant chemotherapy: NSABP protocol B-40
    H D Bear
    Virginia Commonwealth University Masey Cancer Center, Richmond, VA NSABBP Biostatistical Center and University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA University of Pittsburgh Medical Center, Magee Womens Cancer Program, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA NSABP CHUM Hotel Dieu, Montreal, QC, Canada NSABP SCCC CCOP, Winston Salem, NC NSABP San Juan MBCCOP, San Juan, PR University of California, Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA Kaiser Permanente Northern California, Vallejo, CA NSABP Colorado Cancer Research Program, Denver, CO NSABP Northwest Medical Specialties, Tacoma, WA NSABP Kansas City CCOP, Kansas City, MO NSABP Jewish General Hospital, McGill University, Montreal, QC, Canada NSABP Genesys Regional Medical Center, Flint, MI NSABP Dayton CCOP, Dayton, OH NSABP Washington Cancer Institute, Washington Hospital Center, Washington, DC National Surgical Adjuvant Breast and Bowel Project and Aultman Health Foundation, Canton
    J Clin Oncol 29:LBA1005. 2011
    ....
  22. ncbi request reprint A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07
    N Wolmark
    Allegheny General Hosp, Pittsburgh, PA NSABP, Pittsburgh, PA CCOP, Columbus, OH
    J Clin Oncol 26:LBA4005. 2008
    ....
  23. ncbi request reprint Initial safety report of NSABP C-08, a randomized phase III study of modified 5-fluorouracil (5-FU)/leucovorin (LCV) and oxaliplatin (OX) (mFOLFOX6) with or without bevacizumab (bev) in the adjuvant treatment of patients with stage II/III colon cancer
    C J Allegra
    University of Florida, Gainesville, FL University of Pittsburgh, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA Allegheny General Hospital, Pittsburgh, PA
    J Clin Oncol 26:4006. 2008
    ..4006 Background: Bev with FOLFOX is active in advanced colorectal cancer (CRC). The C-08 trial investigates the effectiveness of adding bev to mFOLFOX6 for post-op adjuvant treatment of pts with stage II or III CRC...
  24. ncbi request reprint Is boost therapy necessary in the treatment of DCIS?
    T B Julian
    NSABP Operations and Biostatistical Center, Pittsburgh, PA Allegheny General Hospital, Pittsburgh, PA University of Pittsburgh, Pittsburgh, PA William Beaumont Hospital, Royal Oak, MI Virginia Commonwealth University Medical Center, Massey Cancer Center, Richmond, VA Aultman Cancer Center, Canton, OH
    J Clin Oncol 26:537. 2008
    ..The benefit of boost therapy in patients with DCIS is less certain. We carried out a review of NSABP B-24 to assess the benefit of boost therapy in this randomized trial...
  25. ncbi request reprint Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
    N Wolmark
    National Surgical Adjuvant Breast and Bowel Project NSABP, 320 E North Ave, Pittsburgh, PA 15212, USA
    J Natl Cancer Inst Monogr . 2001
    ..Marginally statistically significant treatment-by-age interactions appear to be emerging for survival and DFS, suggesting that younger patients may benefit from preoperative therapy, whereas the reverse may be true for older patients...
  26. ncbi request reprint Multigene predictors developed on breast cancer cell lines to predict patient chemotherapy response: A validation study on the NSABP B-27 trial
    K Shen
    Precision Therapeutics, Inc, Pittsburgh, PA NSABBP Biostatistical Center and University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA
    J Clin Oncol 29:1029. 2011
    ..Performance was assessed by the prediction of pathological complete response (pCR) in National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-27 clinical trial breast cancer patients...
  27. ncbi request reprint Use of two-year disease-free survival (DFS) as a primary endpoint in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: New data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, NSAPB C-06 and C-07,
    D J Sargent
    Mayo Clinic, Rochester, MN NSABP Biostatistical Center, Pittsburgh, PA University Hospital Gasthuisberg Leuven, Leuven, Belgium Cancer Research UK, Glasgow, United Kingdom Memorial Sloan Kettering Cancer Center, New York, NY Allegheny General Hospital, Pittsburgh, PA IDDI, Louvian La Neuve, Belgium Hospital Saint Antoine, Paris, France
    J Clin Oncol 27:4011. 2009
    ..The relationship between endpoints in more recent trials with oral fluoropyrimidines, oxaliplatin, and irinotecan is unknown...
  28. ncbi request reprint Preliminary results of centralized HER2 testing in DCIS of the breast: NSABP B-43
    K P Siziopikou
    Northwestern University Feinberg School of Medicine, Chicago, IL NSABP Rush University Medical Center, Chicago, IL NSABBP Biostatistical Center and University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Virginia Commonwealth University, Richmond, VA National Surgical Adjuvant Breast and Bowel Project and Aultman Health Foundation, Canton, OH NSABP Colorado Cancer Research Program, Denver, CO NSABP Iowa Oncology Research Association, Des Moines, IA NSABP Florida Cancer Specialists, Sarasota, FL NSABP Reading Regional Cancer Center, West Reading, PA NSABP SCCC CCOP, Winston Salem, NC NSABP Kaiser Permanente Southern California, San Diego, CA NSABP Atlanta Regional Community Clinical Oncology Program, Atlanta, GA Division of Cancer Prevention, National Cancer Institute, Bethesda, MD NSABP University of Colorado, Aurora, CO
    J Clin Oncol 29:588. 2011
    ..There has been no documented centralized multi-institutional HER-2 analysis of DCIS. B-43 provides a unique opportunity to evaluate this question in a large cohort of DCIS patients...
  29. ncbi request reprint Should log odds of positive lymph node be incorporated into AJCC TNM breast cancer staging system?
    J Wang
    University at Buffalo, State University of New York, Buffalo, NY National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Pittsburgh, PA Aultman Cancer Center, Canton, OH National Surgical Adjuvant Breast and Bowel Project Operations Center, Pittsburgh, PA
    J Clin Oncol 26:11037. 2008
    ..This study reports the confirmatory result using patients included in prospective, randomized clinical trials by the NSABP...
  30. ncbi request reprint Effect of axillary dissection for occult detected sentinel nodes metastases on survival: NSABP B-32
    T B Julian
    National Surgical Adjuvant Breast and Bowel Project, Allegheny General Hospital, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project Biostatistical Center University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project, Aultman Health Foundation, Canton, OH National Surgical Adjuvant Breast and Bowel Project, University of Vermont, Burlington, VT National Surgical Adjuvant Breast and Bowel Project, Department of Pathology, University of Vermont College of Medicine, Burlington, VT Department of Medical Biostatistics, University of Vermont College of Medicine, Burlington, VT
    J Clin Oncol 29:80. 2011
    ..SLN paraffin tissue blocks from cases with pathologically negative SLNs were later evaluated centrally for occult metastases deeper in the blocks. This study evaluates group outcomes related to occult metastases...
  31. ncbi request reprint Factors associated with participant adherence in the NSABP Study of Tamoxifen and Raloxifene (STAR)
    W M Cronin
    NSABP Biostatistical Center, Pittsburgh, PA NSABP, Pittsburgh, PA University of Pittsburgh, Pittsburgh, PA
    J Clin Oncol 26:6518. 2008
    ..We have now analyzed STAR data on adherence (taking 2 pills per day) and persistence (willingness to remain on the protocol regimen)...
  32. ncbi request reprint A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08
    N Wolmark
    NSABP, Pittsburgh, PA University of Florida, Gainesville, FL Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA Allegheny General Hospital, Pittsburgh, PA Southeast Cancer Control Consortium CCOP, Goldsboro, NC Atlanta Cancer Care, Atlanta, GA Kaiser Permanente Northern California, Vallejo, CA All Ireland Cooperative Oncology Research Group, Dublin, Ireland
    J Clin Oncol 27:LBA4. 2009
    ..No significant financial relationships to disclose...
  33. ncbi request reprint Epirubicin plus cyclophosphamide followed by docetaxel plus trastuzumab and bevacizumab as neoadjuvant therapy for HER2-positive locally advanced breast cancer (LABC) or as adjuvant therapy for HER2-positive pathologic stage III breast cancer (PS3BC): A p
    J W Smith
    Columbia River Oncology Program, Portland, OR International Drug Development Institute IDDI, Louvain la Neuve, Belgium National Surgical Adjuvant Breast and Bowel Project NSABP, Pittsburgh, PA UPCI Magee Womens Hospital Womens Cancer Clinic, Pittsburgh, PA Allegheny General Hospital, Pittsburgh, PA University of Pittsburgh Cancer Institute, Pittsburgh, PA Centre Hospitalier Universite de Montreal, Montreal, QC, Canada
    J Clin Oncol 27:580. 2009
    ..The purpose of this trial is to determine the cardiac safety profile of these agents with docetaxel (T) following epirubicin plus cyclophosphamide (EC) in women with LABC and PS3BC and the activity in those with LABC...
  34. ncbi request reprint Quality of life in breast cancer patients receiving sentinel-node (SN) biopsy alone or with axillary dissection (AD): Results from NSABP Protocol B-32
    S R Land
    NSABP, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA University of British Columbia, Vancouver, BC, Canada University of Pittsburgh, Pittsburgh, PA University of Vermont, Burlington, VT Jonsson Comprehensive Cancer Center, Los Angeles, CA NSABP, Allegheny General Hospital, Pittsburgh, PA
    J Clin Oncol 26:9533. 2008
    ..We report the final treatment (TX) comparison of PROs...
  35. ncbi request reprint Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial
    T B Julian
    National Surgical Adjuvant Breast and Bowel Project and Allegheny General Hospital, Pittsburgh, PA Biostatistical Center, National Surgical Adjuvant Breast and Bowel Project and Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA William Beaumont Hospital, Royal Oak, MI Radiation Therapy Oncology Group and Medical College of Wisconsin, Milwaukee, WI RTOG Statistical Center, Philadelphia, PA National Surgical Adjuvant Breast and Bowel Project and Virginia Commonwealth University, Richmond, VA National Surgical Adjuvant Breast and Bowel Project and Arizona Breast Cancer Specialists, Scottsdale, AZ NSABP University of Colorado, Aurora, CO NSABP and Allegheny General Hospital, Pittsburgh, PA National Surgical Adjuvant Breast and Bowel Project and Aultman Health Foundation, Canton, OH Radiation Therapy Oncology Group and Emory University, Atlanta, GA
    J Clin Oncol 29:1011. 2011
    ..Given those results, we believe it necessary to report the current levels of toxicity in the 3-D conformal portion of the APBI arm of our trial...
  36. doi request reprint Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABPĀ Foundation FB-6, a phase II study
    A R Tan
    National Surgical Adjuvant Breast and Bowel Project NSABP Foundation, Pittsburgh, PA, USA
    Breast Cancer Res Treat 149:163-9. 2015
    ..The combination does not appear to warrant further evaluation in the neoadjuvant setting for breast cancer...